Tirzepatide L-carnitine dosage chart with unit conversions, titration steps, and vial concentrations, plus safety notes and what to ask your prescriber.
Tirzepatide with L-carnitine does not have a single official dosage chart, because no FDA-approved medicine combines the two ingredients. The tirzepatide portion follows the standard titration used for Mounjaro and Zepbound: 2.5 mg once weekly for four weeks, then 5 mg weekly, increasing in 2.5 mg steps up to a maximum of 15 mg per week. The L-carnitine portion is whatever the compounding pharmacy added, most often 100 mg per mL, and your dose in syringe units depends entirely on the tirzepatide concentration printed on the vial.
What "Tirzepatide With L-Carnitine" Actually Means
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is FDA-approved as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management.
L-carnitine is a supplement ingredient that helps shuttle fatty acids into mitochondria, where the body burns them for energy. It is not an FDA-approved drug, and it does not appear in any brand-name tirzepatide product.
Some 503A and 503B compounding pharmacies combine the two in one vial, commonly at 10 mg/mL or 20 mg/mL of tirzepatide with 100 mg/mL of L-carnitine. The most common stated reason is comfort, since L-carnitine may reduce the stinging that some people feel with a concentrated peptide injection.
Compounded tirzepatide is not FDA-approved for human use, and the FDA has moved to restrict large-scale compounding since the brand-name shortage ended. Verify that any pharmacy you use holds a current state license.
Standard Tirzepatide Titration Schedule
The standard tirzepatide dosage chart below matches the escalation schedule used in the SURPASS and SURMOUNT clinical trials. Prescribers rarely skip steps, because nausea, vomiting, and diarrhea tend to worsen as the dose rises.
| Phase | Weekly tirzepatide dose | Typical duration |
|---|---|---|
| Start | 2.5 mg | 4 weeks |
| Step 2 | 5 mg | 4 weeks |
| Step 3 | 7.5 mg | 4 weeks |
| Step 4 | 10 mg | 4 weeks |
| Step 5 | 12.5 mg | 4 weeks |
| Step 6 | 15 mg (maximum) | Ongoing |
If you are following a tirzepatide dosage chart for weight loss, the ladder is identical to the diabetes schedule. What changes is the maintenance dose and how long you stay at each step.
Many people remain at 5 mg or 7.5 mg for months when appetite control is adequate. Doses above 15 mg per week are not recommended, and no trial has shown extra benefit beyond that ceiling.
Converting Milligrams to Syringe Units
You cannot convert milligrams to units without knowing the concentration. A 5 mg dose equals 50 units in a 10 mg/mL vial, but only 25 units in a 20 mg/mL vial.
Insulin syringes sold in the United States are typically U-100, meaning 100 units equal 1 mL. Multiply the volume in mL by 100 to get units.
| Tirzepatide concentration | 2.5 mg | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| 5 mg/mL | 0.5 mL (50 units) | 1 mL (100 units) | 2 mL (200 units) | 3 mL (300 units) |
| 10 mg/mL | 0.25 mL (25 units) | 0.5 mL (50 units) | 1 mL (100 units) | 1.5 mL (150 units) |
| 20 mg/mL | 0.125 mL (12.5 units) | 0.25 mL (25 units) | 0.5 mL (50 units) | 0.75 mL (75 units) |
| 30 mg/mL | 0.083 mL (about 8 units) | 0.167 mL (about 17 units) | 0.333 mL (about 33 units) | 0.5 mL (50 units) |
Notice how the 5 mg/mL column produces volumes too large for a standard 1 mL syringe. That concentration is usually reserved for the earliest titration steps only.
Vial size is not the same as concentration
If you are searching for a tirzepatide 30 mg vial dosage chart, remember that the 30 refers to the total milligrams in the vial, not milligrams per mL. A 30 mg vial could be 10 mg/mL in a 3 mL vial or 30 mg/mL in a 1 mL vial.
Those two products require completely different injection volumes for the same milligram dose. Always read the concentration line on the label, not the number on the front of the box.
How much L-carnitine each dose actually delivers
| Tirzepatide dose | Volume at 10 mg/mL | L-carnitine delivered at 100 mg/mL |
|---|---|---|
| 2.5 mg | 0.25 mL | 25 mg |
| 5 mg | 0.5 mL | 50 mg |
| 7.5 mg | 0.75 mL | 75 mg |
| 10 mg | 1 mL | 100 mg |
These amounts sit far below the 500 mg to 2,000 mg daily doses used in oral L-carnitine research. Treat the carnitine as a formulation additive rather than a therapeutic dose of its own.
L-Carnitine Side Effects and Interactions
L-carnitine is generally well tolerated at the amounts found in compounded tirzepatide. Larger intakes can cause stomach upset, and some people report a fishy body odor.
- Levothyroxine: L-carnitine may interfere with thyroid hormone absorption, so separating doses and telling your prescriber matters.
- Warfarin: Case reports describe rising INR in people taking L-carnitine, which can increase bleeding risk.
- Seizure history: L-carnitine may lower the seizure threshold in some patients.
Tirzepatide itself carries the larger risk profile. Common effects include nausea, constipation, diarrhea, and fatigue, while rare but serious risks include pancreatitis, gallbladder disease, and gastroparesis.
Tirzepatide is contraindicated for people with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. Tell your prescriber about every medication and supplement you take.
Charts for Other Peptides Are Not Interchangeable
Search results frequently blend unrelated injectables into one conversation. A lipo-c peptide dosage chart describes a methionine, inositol, and choline blend, which is a different product with a different purpose.
Likewise, a bpc-157 dosage chart by weight applies to a research peptide studied for tendon and gut healing, not to a GLP-1 medication. Comparing compounds by name alone leads to dosing errors.
Always match the chart to the exact active ingredient, concentration, and route printed on your own vial.
Questions to Ask Before You Inject
Bring the vial to your appointment or send the pharmacy a photo, then confirm the following points with a licensed healthcare professional.
- What is the tirzepatide concentration in mg/mL?
- How many units should I draw for my current dose?
- Which syringe size and needle length should I use?
- How long can the vial be used after the first puncture?
- Which side effects mean I should stop and call you immediately?
Compounded tirzepatide is not FDA-approved, and dosing errors with concentrated vials are a real and preventable source of harm. Never change your dose based on someone else's chart or a social media post.
Frequently Asked Questions
What is the starting dose of compounded tirzepatide with L-carnitine?
Most prescribers start tirzepatide at 2.5 mg once weekly for four weeks, regardless of whether the vial also contains L-carnitine. After that, the dose typically increases to 5 mg weekly, then rises in 2.5 mg steps as tolerated. L-carnitine does not change the tirzepatide titration schedule.
How many units is 5 mg of tirzepatide with L-carnitine?
It depends entirely on the concentration on the vial. A 5 mg dose is 50 units in a 10 mg/mL product, 25 units in a 20 mg/mL product, and 1 mL (100 units) in a 5 mg/mL product. Always confirm the concentration and your calculated units with your prescriber or pharmacist.
Does the L-carnitine in compounded tirzepatide help with weight loss?
There is no strong clinical evidence that the small amount of L-carnitine in these vials adds meaningful weight loss beyond tirzepatide itself. A typical 5 mg dose delivers only about 50 mg of carnitine, far below the 500 mg to 2,000 mg used in oral supplement studies. Compounded tirzepatide is also not FDA-approved, so discuss risks and benefits with a licensed healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.